Table:
|  |  | Fiscal Year Ended September 28, 2019 |  |  |
| --- | --- | --- | --- | --- |
|  |  | Reportable Segment: |  |  |
|  | AMER | APAC | EMEA | Total |
| Market Sector: |  |  |  |  |
| Healthcare/Life Sciences | $488,851 | $602,922 | $128,225 | $1,219,998 |
| Industrial/Commercial | 359,381 | 534,971 | 86,868 | 981,220 |
| Aerospace/Defense | 317,558 | 186,486 | 84,556 | 588,600 |
| Communications | 256,523 | 113,329 | 4,764 | 374,616 |
| External revenue | 1,422,313 | 1,437,708 | 304,413 | 3,164,434 |
| Inter-segment sales | 6,995 | 119,497 | 5,520 | 132,012 |
| Segment revenue | $1,429,308 | $1,557,205 | $309,933 | $3,296,446 |
Paragraphs:
Disaggregated Revenue
The table below includes the Company’s revenue for the fiscal year ended September 28, 2019 disaggregated by geographic reportable segment and market sector (in thousands):
Question:
What was the total revenue from the Healthcare/Life Sciences segment?